Obesity crisis deepens, weight-loss drug subsidy debate reignited
With 4 in 5 older Australians overweight, experts debate PBS subsidies for drugs like Ozempic. Could wider access solve the crisis? Read the latest analysis.
With 4 in 5 older Australians overweight, experts debate PBS subsidies for drugs like Ozempic. Could wider access solve the crisis? Read the latest analysis.
From a former NRLW player facing DV charges to a nude sunbather at Fairy Meadow, here's a wrap-up of the notable cases in Illawarra courts this week. Read the full details.
ACT Senate candidate Nick Tyrrell calls for a childcare overhaul, proposing tax breaks for nannies and payments for grandparents to give parents more flexible options.
A Wollongong court delays the case of a grandmother accused of stabbing her family, with claims the diabetes drug Ozempic triggered violent behaviour. Read the latest.
Fresh research warns weight loss drug users must include regular weight-bearing exercise to prevent serious muscle and bone deterioration. Experts urge action as PBS listing looms.
A NSW woman's rapid 10kg weight loss using GLP-1 drugs like Ozempic highlights a hidden danger: muscle loss. New research warns exercise is not optional. Read her story.
New research reveals most weight lost using popular GLP-1 drugs like Ozempic is regained within two years of stopping treatment. Learn the long-term implications.
A major childcare subsidy change guarantees eligible Australian families three days of subsidised care per week, removing activity tests. Find out if you qualify.
Cairns Hospital faces a $5.3 million blowout in patient travel subsidies, with disruptive groups drinking near the facility creating major access issues. Learn how this impacts healthcare delivery.
The Coalition plans to abolish the electric vehicle FBT exemption, potentially increasing transport costs for thousands of Canberra drivers who've embraced the popular subsidy.
Groundbreaking international trial testing if weight loss medications can treat alcohol addiction and liver disease. Australian researchers report promising early results.